These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1344442)

  • 21. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective.
    Wong JB; Kaplan MM; Meyer KB; Pauker SG
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):741-60. PubMed ID: 2261914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
    Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.
    Willegaignon J; Guimarães MI; Stabin MG; Sapienza MT; Malvestiti LF; Marone MM; Sordi GM
    Health Phys; 2007 Dec; 93(6):678-88. PubMed ID: 17993848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
    Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H
    Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid changes after high dose radioactive iodine in patients with thyroid cancer.
    Guven A; Salman S; Boztepe H; Yarman S; Tanakol R; Azizlerli H; Alagol F
    Ann Nucl Med; 2009 Jul; 23(5):437-41. PubMed ID: 19455388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
    Willegaignon J; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Clin Nucl Med; 2011 Jun; 36(6):440-5. PubMed ID: 21552020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of radioactive iodine in the treatment of differentiated thyroid cancer: physiopathological basis, results, considerations from the viewpoint of radioprotection].
    Frühling J
    Bull Mem Acad R Med Belg; 1994; 149(3-4):195-206; discussion 206-8. PubMed ID: 7841930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
    Murcutt G; Edwards J; Boakye J; Davenport A
    Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
    Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Shielding effect of distance in (131)I-131 therapy for differentiated thyroid cancer].
    Chi X; Liu F; Li G; Wang Q; Deng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):286-8. PubMed ID: 24589615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of the external dose measurement of the patients treated with radioiodine therapy.
    Mulazimoglu M; Edis N; Tamam MO; Uyanik E; Ozpacaci T
    Radiat Prot Dosimetry; 2010 Oct; 141(3):233-8. PubMed ID: 20624753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The external radiotherapy of differentiated thyroid carcinoma].
    Sautter-Bihl ML; Heinze HG
    Dtsch Med Wochenschr; 1992 Apr; 117(17):665-8. PubMed ID: 1369745
    [No Abstract]   [Full Text] [Related]  

  • 40. Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area.
    Kim HK; Lee SY; Lee JI; Jang HW; Kim SK; Chung HS; Tan AH; Hur KY; Kim JH; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):851-6. PubMed ID: 21707689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.